The RADAR-AD smart home study recently began. The first participant in the RADAR-AD tier 3 study was included on 25 November 2021 in Thessaloniki, Greece. The tier 3 study is a pioneer study in which participants visit RADAR-AD’s smart home that utilises remote measurement technologies (RMTs) to detect and capture performance ranging from activities of daily living to physiological measurements and sleep. This is employed in a realistic domestic smart home environment to validate its efficiency and effectiveness.
The outcomes of the tier 3 study will provide RADAR-AD researchers with an insight into the potential of technological solutions to be incorporated into the daily activity of people living with more advanced stages of cognitive impairment with the goal to explain cognitive decline over time in an unobtrusive and objective way. Read the full news story here. RADAR-AD is a collaborative research initiative that explores the potential of mobile and digital technologies to improve the assessment of Alzheimer’s disease (AD). The AD terminology in the RADAR-AD project reflects the recent conceptualisation of AD as covering the full spectrum of the disease, including both pre-dementia (preclinical and prodromal AD) and dementia phases (mild to severe AD dementia).
This project builds on the knowledge and experience gained in a sister project called RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System), which was launched in 2016 to explore remote monitoring in people living with multiple sclerosis, epilepsy and depression. The RADAR-AD project has received support from the Innovative Medicines Initiative Joint Undertaking (JU) under grant agreement n° 806999. The JU receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA.